IMMUNOLOGICAL ABNORMALITIES IN PATIENTS WHO HAD THE OCULOMUCOCUTANEOUS SYNDROME ASSOCIATED WITH PRACTOLOL THERAPY
- 1 November 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 308 (7993) , 984-987
- https://doi.org/10.1016/s0140-6736(76)90831-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Practolol and the nephrotic syndrome.BMJ, 1975
- Fibrinous peritonitis: a complication of practolol therapy.BMJ, 1975
- Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.BMJ, 1975
- Untoward effects associated with practolol administration: oculomucocutaneous syndrome.BMJ, 1975
- SCLEROSING PERITONITIS AND PRACTOLOLThe Lancet, 1975
- SCLEROSING PERITONITIS, AN UNUSUAL REACTION TO A β-ADRENERGIC-BLOCKING DRUG (PRACTOLOL)The Lancet, 1974
- Cutaneous and Ocular Reactions to PractololBMJ, 1974
- Systemic Lupus Erythematosus Syndrome Induced by PractololBMJ, 1973
- EXFOLIATIVE DERMATITIS AND PRACTOLOLThe Lancet, 1972
- Measurement of Serum DNA-Binding Activity in Systemic Lupus ErythematosusNew England Journal of Medicine, 1969